Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis
Previous estimates of the magnitude of this issue have not accounted for ongoing inflammation as the potential cause. Of 3370 studies identified, 27 were eligible, of which 18 were newly identified. Among 3169 patients with IBD in remission, 32% had IBS-type symptoms. Prevalence was lower when remission was defined by endoscopic assessment or histological assessment.
